lithium has been researched along with Hypomania in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 32 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Nomura, I; Okuya, M; Sakuma, K | 1 |
| Akhondzadeh, S; Badrfam, R; Farid, M; Khaleghi, A; Mohammadi, MR; Mohammadian Khonsari, N; Mostafavi, SA; Zandifar, A | 1 |
| Akbarzadeh, F; Dadgar Moghaddam, M; Eslamzadeh, M; Fayyazi Bordbar, MR; Mokhber, N; Ziaee, M; Zolfaghari, M | 1 |
| Ahmadpanah, M; Brand, S; Brühl, AB; Jahangard, L; Keshavarzi, A; Sharifi, A; Soltanian, A | 1 |
| Fountoulakis, KN; Tohen, M; Zarate, CA | 1 |
| Amoretti, S; Anmella, G; Fico, G; Hidalgo-Mazzei, D; Murru, A; Pacchiarotti, I; Radua, J; Sagué-Vilavella, M; Verdolini, N; Vieta, E | 1 |
| Altun, A; Çiçekli, MN; Günaydın, C; Tiryaki, ES | 1 |
| Carvalho, AF; Hsu, CW; Kao, HY; Liang, CS; Lin, PY; Stubbs, B; Tsai, SY; Tseng, PT; Tu, YK; Vieta, E | 1 |
| Adler, CM; DelBello, MP; Fleck, D; Gong, Q; Klein, CC; Lei, D; Li, W; Lui, S; Mechelli, A; Patino, LR; Pinaya, WHL; Qin, K; Strawn, JR; Sweeney, JA; Tallman, MJ | 1 |
| Anderau, S; Marshall, DF; McInnis, MG; Sekula, NM; Yocum, AK | 1 |
| Adler, CM; DelBello, MP; Fleck, DE; Gong, Q; Lei, D; Li, W; Lui, S; Nery, FG; Rodrigo Patino, L; Rummelhoff, E; Strakowski, SM; Strawn, JR; Sweeney, JA; Tallman, MJ; Welge, JA | 1 |
| Abedini, T; Akhondzadeh, S; Ardakani, MK; Ghannadi, F; Hosseyni, R; Moghaddam, HS; Talaei, A | 1 |
| Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J | 1 |
| Adler, CM; Ai, Y; Blom, TJ; DelBello, MP; Fleck, DE; Gong, Q; Klein, CC; Lei, D; Li, W; Patino, LR; Qin, K; Strawn, JR; Sweeney, JA; Tallman, MJ; Welge, JA | 1 |
| Gao, TH; Li, T; Ma, XH; Ni, PY; Ni, RJ; Tian, Y; Wang, YY; Wei, JX; Zhao, LS | 1 |
| Bessa, G; Cousins, DA; Freitas, HLO; Juruena, MF; Kerr-Gaffney, J; Loschi, G; Pires, H; Strawbridge, R; Young, AH | 1 |
| Alda, M; Gershon, E; Kelsoe, JR; Maihofer, AX; Mandyam, AD; McCarthy, MJ; McInnis, MG; Mishra, HK; Nievergelt, CM; Shilling, PD; Trenet, W; Wei, H | 1 |
| Arcos-Burgos, M; Castaño, M; Cuartas, M; Díaz-Zuluaga, AM; López-Jaramillo, C; Palacio, JD; Valencia, J; Vélez, JI | 1 |
| Aguiar-Geraldo, JM; Menegas, S; Peper-Nascimento, J; Possamai-Della, T; Quevedo, J; Valvassori, SS | 1 |
| Bekar, LK; Pacholko, AG | 1 |
| de Leeuw, M; Giltay, EJ; Riedinger, MA; van der Wee, NJA | 1 |
| Abé, C; Bergen, SE; Ekman, CJ; Ingvar, M; Landén, M; Liberg, B; Petrovic, P; Sellgren, CM; Song, J | 1 |
| Aguiar-Geraldo, JM; Andersen, ML; Cararo, JH; Dal-Pont, GC; Menegas, S; Possamai-Della, T; Quevedo, J; Valvassori, SS; Varela, RB | 1 |
| Barichello, T; Chaves Filho, AJM; Cunha, NL; de Lucena, D; de Queiroz, T; de Souza, AG; Jucá, PM; Macedo, DS; Oliveira, JVS; Quevedo, J; Soares, MV; Valvassori, SS | 1 |
| Abé, C; Ingvar, M; Landén, M; Liberg, B; Petrovic, P | 1 |
| Quiroz, D; Strejilevich, SA | 1 |
| Ayala, K; Collins, L; Ettenberg, A; Fisher, MPA; Krug, JT; Mayes, MS | 1 |
| Cai, Y; Cao, B; Cao, L; Chen, J; Chen, Y; Cheng, D; Cheng, X; Cui, L; Deng, W; Greenshaw, AJ; Lan, X; Li, S; Li, T; Li, X; Liu, C; Liu, Y; Mai, S; Sawalha, J; Soares, JC; Sun, J; Tan, J; Wu, Q; Yang, C; Ye, B; Yousefnezhad, M; Zhang, B; Zhang, X; Zhang, Y; Zhao, L; Zheng, C; Zou, W | 1 |
| Berk, M; Brietzke, E; Goldstein, BI; Kessing, LV; López-Jaramillo, C; Majeed, A; Malhi, GS; Mansur, RB; McIntyre, RS; Nierenberg, AA; Rosenblat, JD; Vieta, E; Vinberg, M; Young, AH | 1 |
| Bona, NP; de Mattos, BDS; Gamaro, GD; Pedra, NS; Recart, VM; Soares, MSP; Spanevello, R; Spohr, L; Stefanello, F; Teixeira, FC | 1 |
| Banach, E; Bukowska-Olech, E; Celichowski, P; Kołodziejski, PA; Langwiński, W; Nogowski, L; Nowakowska, J; Pawlak, J; Pruszyńska-Oszmałek, E; Rybakowski, JK; Sakrajda, K; Sassek, M; Socha, M; Szczepankiewicz, A; Szczepankiewicz, D; Twarowska-Hauser, J; Zakowicz, P | 1 |
| Parker, G; Ricciardi, T; Spoelma, MJ; Tavella, G | 1 |
7 review(s) available for lithium and Hypomania
| Article | Year |
|---|---|
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; Haloperidol; Humans; Lithium; Male; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tamoxifen; Valproic Acid | 2022 |
Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Humans; Lithium; Lithium Compounds; Mania; Randomized Controlled Trials as Topic | 2022 |
Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis.
Topics: Bipolar Disorder; Depression; Humans; Lithium; Lithium Compounds; Mania | 2022 |
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzocycloheptenes; Haloperidol; Humans; Lithium; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Piperazines; Quetiapine Fumarate; Risperidone; Tamoxifen; Thiazoles; Valproic Acid | 2022 |
Identifying the neuropsychiatric health effects of low-dose lithium interventions: A systematic review.
Topics: Adult; Antipsychotic Agents; Humans; Lithium; Mania; Mood Disorders | 2023 |
Lithium in bipolar depression: A review of the evidence.
Topics: Bipolar Disorder; Humans; Lithium; Lithium Compounds; Mania | 2023 |
Bipolar disorders.
Topics: Adolescent; Adult; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Cardiovascular Diseases; Child; Child Abuse; Comorbidity; Depressive Disorder, Major; Environmental Exposure; Humans; Lamotrigine; Lithium; Mania; Suicide; Suicide Prevention; Valproic Acid; Young Adult | 2020 |
7 trial(s) available for lithium and Hypomania
| Article | Year |
|---|---|
The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double-blind, randomized, placebo-controlled, clinical trial.
Topics: Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Humans; Lithium; Mania; Psychiatric Status Rating Scales; Treatment Outcome; Vitamin B 6 | 2021 |
Personality profile and therapeutic response to lithium carbonate and sodium valproate in mania with psychotic features.
Topics: Antimanic Agents; Humans; Lithium; Lithium Carbonate; Mania; Personality; Valproic Acid | 2022 |
Levetiracetam as an Adjunctive Treatment for Mania: A Double-Blind, Randomized, Placebo-Controlled Trial.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Female; Humans; Levetiracetam; Lithium; Male; Mania; Psychiatric Status Rating Scales; Treatment Outcome | 2022 |
Brain morphometric features predict medication response in youth with bipolar disorder: a prospective randomized clinical trial.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Brain; Child; Double-Blind Method; Humans; Lithium; Mania; Prospective Studies; Quetiapine Fumarate; Treatment Outcome | 2023 |
Changes in the structural brain connectome over the course of a nonrandomized clinical trial for acute mania.
Topics: Brain; Connectome; Humans; Lithium; Magnetic Resonance Imaging; Mania; Quetiapine Fumarate | 2022 |
Efficacy and safety of palmitoylethanolamide as an adjunctive treatment for acute mania: A randomized, double-blind, placebo-controlled trial.
Topics: Amides; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Humans; Lithium; Mania; Palmitic Acids; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome | 2022 |
Effects of short-term quetiapine and lithium therapy for acute manic or mixed episodes on the limbic system and emotion regulation circuitry in youth with bipolar disorder.
Topics: Adolescent; Amygdala; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Emotional Regulation; Humans; Lithium; Lithium Compounds; Magnetic Resonance Imaging; Mania; Quetiapine Fumarate | 2023 |
18 other study(ies) available for lithium and Hypomania
| Article | Year |
|---|---|
Lamotrigine-induced mania: warning report for the identification of vulnerable populations and expert clinical recommendations for prescription.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Aripiprazole; Female; Glutamates; Humans; Infant; Lamotrigine; Lithium; Lurasidone Hydrochloride; Male; Mania; Prescriptions; Vulnerable Populations | 2022 |
GLP-1 agonist liraglutide improves ouabain-induced mania and depressive state
Topics: Animals; Antioxidants; Glucagon-Like Peptide 1; Glutathione; Glycogen Synthase Kinase 3 beta; Liraglutide; Lithium; Mania; Ouabain; Oxidants; Rats; Sucrose; Valproic Acid | 2022 |
Lithium use associated with symptom severity in comorbid bipolar disorder I and migraine.
Topics: Bipolar Disorder; Humans; Lithium; Longitudinal Studies; Mania; Migraine Disorders; Prospective Studies; Quality of Life | 2022 |
Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway.
Topics: Animals; Antidepressive Agents; Depressive Disorder, Major; Ketamine; Lithium; Lithium Compounds; Male; Mammals; Mania; Mice; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Rodent Diseases; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Neural progenitor cells derived from lithium responsive and non-responsive bipolar disorder patients exhibit distinct sensitivity to cell death following methamphetamine.
Topics: Antimanic Agents; Bipolar Disorder; Dopamine; Humans; Lithium; Lithium Compounds; Mania; Methamphetamine; Neural Stem Cells | 2023 |
Ancestry component as a major predictor of lithium response in the treatment of bipolar disorder.
Topics: Bipolar Disorder; Humans; Lithium; Lithium Compounds; Mania | 2023 |
Folic acid does not have an anti-manic effect but protect the brain against oxidative stress in an animal model of mania induced by ouabain.
Topics: Animals; Antimanic Agents; Behavior, Animal; Brain; Disease Models, Animal; Folic Acid; Lithium; Male; Mania; Ouabain; Oxidative Stress; Rats; Rats, Wistar | 2023 |
Different pharmacokinetics of lithium orotate inform why it is more potent, effective, and less toxic than lithium carbonate in a mouse model of mania.
Topics: Amphetamine; Animals; Antimanic Agents; Bipolar Disorder; Disease Models, Animal; Female; Lithium; Lithium Carbonate; Male; Mania; Mice | 2023 |
Longitudinal Cortical Thickness Changes in Bipolar Disorder and the Relationship to Genetic Risk, Mania, and Lithium Use.
Topics: Bipolar Disorder; Humans; Lithium; Magnetic Resonance Imaging; Mania; Temporal Lobe | 2020 |
Efficacy of folic acid as an adjunct to lithium therapy on manic-like behaviors, oxidative stress and inflammatory parameters in an animal model of mania.
Topics: Amphetamine; Animals; Antimanic Agents; Central Nervous System Stimulants; Disease Models, Animal; Drug Therapy, Combination; Folic Acid; Inflammation Mediators; Lithium; Male; Mania; Oxidative Stress; Rats; Rats, Wistar; Treatment Outcome | 2020 |
The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory deficits induced by D-amphetamine and augments lithium effects in mice: Relevance for bipolar disorder.
Topics: Animals; Bipolar Disorder; Dextroamphetamine; Drug Synergism; Glucagon-Like Peptide-1 Receptor; Lipid Peroxidation; Liraglutide; Lithium; Male; Mania; Memory Disorders; Mice | 2020 |
Reply to: Tripping Over the Same Stone.
Topics: Bipolar Disorder; Humans; Lithium; Mania | 2020 |
Tripping Over the Same Stone.
Topics: Bipolar Disorder; Humans; Lithium; Mania | 2020 |
Differential effects of lithium isotopes in a ketamine-induced hyperactivity model of mania.
Topics: Animals; Antimanic Agents; Behavior, Animal; Disease Models, Animal; Isotopes; Ketamine; Lithium; Lithium Chloride; Locomotion; Male; Mania; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2020 |
CACNB2 rs11013860 polymorphism correlates of prefrontal cortex thickness in bipolar patients with first-episode mania.
Topics: Bipolar Disorder; Calcium Channels, L-Type; Humans; Lithium; Magnetic Resonance Imaging; Mania; Prefrontal Cortex | 2020 |
Gallic acid protects cerebral cortex, hippocampus, and striatum against oxidative damage and cholinergic dysfunction in an experimental model of manic-like behavior: Comparison with lithium effects.
Topics: Animals; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Gallic Acid; Hippocampus; Lithium; Male; Mania; Motor Activity; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species | 2021 |
Transcriptome Changes in Three Brain Regions during Chronic Lithium Administration in the Rat Models of Mania and Depression.
Topics: Animals; Antidepressive Agents; Antimanic Agents; Brain; Depression; Disease Models, Animal; Lithium; Male; Mania; Rats; Rats, Wistar; Transcriptome | 2021 |
The utility of daily mood ratings in clinical trials of patients with bipolar II disorder.
Topics: Affect; Bipolar Disorder; Humans; Lamotrigine; Lithium; Mania | 2021 |